A Study of the Natural Progression of Interstitial Lung Disease (ILD)

ConditionsInterstitial Lung Diseases Idiopathic Pulmonary Fibrosis Sarcoidosis Connective Tissue Disorder

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity of Chicago

About this trial

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Eligibility criteria

Qualifiers

Interstitial lung disease

Disqualifiers

Does not have Interstitial lung disease

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University of Chicago

Lead sponsor

Idiopathic Pulmonary Fibrosis Clinical Research Network

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Source ClinicalTrials.gov